Inside the Mafia of Pharma Pricing - BIG by Matt Stoller
4% of all the money in America flows through a few mafia-like health care conglomerates. The FTC just released a ground-breaking report on how they operate. And it is gearing up to sue.
Inside the Mafia of Pharma Pricing 4% of all the money in America flows through a few mafia-like health care conglomerates. The FTC just released a ground-breaking report on how they operate. And it is gearing up to sue. Matt Stoller Jul 15, 2024 338 17 48 Share Welcome to BIG, a newsletter on the politics of monopoly power. If you’d like to sign up to receive issues over email, you can do so here . In 2022, an executive at a health insurance company expressed concern at the games his company was playing with drug prices. He pointed at the drug Gleevec, which when it was approved in 2001, was
Explore this link on the map →saved by
related reading
- How PBMs can use private-labelled drug products as a great escape from anti-steering policies - 46brooklyn Research46brooklyn.com
- Understanding the Role of the PBMpriorauthtraining.org
- The Fiduciary Obligation to Avoid 56,000% Markups on Rxgottwals.substack.com
- How pharmacies, drug makers, PBMs and health plans are benefiting from your Rx benefits!healthtechstack.io
- Amazon’s Antitrust Paradox | Yale Law Journalyalelawjournal.org
- 392: Someone Else's Money - This American Lifethisamericanlife.org
- Why are our medicines so expensive? Spoiler: Not for the reasons you are being told… - PMCncbi.nlm.nih.gov
- Understanding Drug Pricing from Divergent Perspectives: State of Washington Prescription Drug Pricing Analysis - 3 ∆XIS Advisors3axisadvisors.com
- Pharma Virumque | Slate Star Codexslatestarcodex.com
- Joe Biden Lowered Drug Prices. Does Anyone Care? - The Atlantictheatlantic.com
- Reddit - Please wait for verificationreddit.com
- The Ezra Klein Show: VC Bill Gurley on Transforming Health Care - Above the CrowdAbove the Crowd | By Bill Gurleyabovethecrowd.com